Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

被引:1854
作者
Kellum, John A. [1 ]
Lameire, Norbert [2 ]
机构
[1] Univ Pittsburgh, CRISMA Ctr, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA
[2] Ghent Univ Hosp, B-9000 Ghent, Belgium
来源
CRITICAL CARE | 2013年 / 17卷 / 01期
关键词
ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; LIPOSOMAL AMPHOTERICIN-B; LOW-DOSE DOPAMINE; EMPIRICAL ANTIFUNGAL THERAPY; PLACEBO-CONTROLLED TRIAL; BETA-LACTAM MONOTHERAPY; GROWTH-FACTOR I; DOUBLE-BLIND; REPLACEMENT THERAPY;
D O I
10.1186/cc11454
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acute kidney injury (AKI) is a common and serious problem affecting millions and causing death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes completed the first ever, international, multidisciplinary, clinical practice guideline for AKI. The guideline is based on evidence review and appraisal, and covers AKI definition, risk assessment, evaluation, prevention, and treatment. In this review we summarize key aspects of the guideline including definition and staging of AKI, as well as evaluation and nondialytic management. Contrast-induced AKI and management of renal replacement therapy will be addressed in a separate review. Treatment recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the Grading of Recommendations Assessment, Development and Evaluation approach. Limitations of the evidence are discussed and a detailed rationale for each recommendation is provided.
引用
收藏
页数:15
相关论文
共 148 条
  • [1] Modified RIFLE criteria in critically ill children with acute kidney injury
    Akcan-Arikan, A.
    Zappitelli, M.
    Loftis, L. L.
    Washburn, K. K.
    Jefferson, L. S.
    Goldstein, S. L.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (10) : 1028 - 1035
  • [2] Study of renal safety in amphotericin B lipid complex-treated patients
    Alexander, BD
    Wingard, JR
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 : S414 - S421
  • [3] A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides
    Ali, MZ
    Goetz, MB
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 796 - 809
  • [4] Incidence and outcomes in acute kidney injury: A comprehensive population-based study
    Ali, Tariq
    Khan, Izhar
    Simpson, William
    Prescott, Gordon
    Townend, John
    Smith, William
    MacLeod, Alison
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04): : 1292 - 1298
  • [5] Anaritide in acute tubular necrosis
    Allgren, RL
    Marbury, TC
    Rahman, SN
    Weisberg, LS
    Fenves, AZ
    Lafayette, RA
    Sweet, RM
    Genter, FC
    Kurnik, BRC
    Conger, JD
    Sayegh, MH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) : 828 - 834
  • [6] [Anonymous], 2006, COCHRANE DB SYST REV
  • [7] [Anonymous], 2009, J AM SOC NEPHROL
  • [8] Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
  • [9] Aminoglycoside-associated nephrotoxicity in the elderly
    Baciewicz, AM
    Sokos, DR
    Cowan, RI
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (02) : 182 - 186
  • [10] A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients
    Bagshaw, Sean M.
    George, Carol
    Dinu, Irina
    Bellomo, Rinaldo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) : 1203 - 1210